Business / Finance

RSS

HealthSouth agrees to acquire Cardinal Hill Rehabilitation Hospital from Kentucky Easter Seal Society

HealthSouth Corporation today announced it has entered into an agreement to purchase Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky, from the Kentucky Easter Seal Society, Inc.

3 Feb 2015

Three CRO Enterprise Partners expand agreements with DATATRAK

DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced three CRO Enterprise Partners have expanded their agreements. These industry-leading organizations have chosen to boost their global licensing capacity and extended their relationship with DATATRAK.

3 Feb 2015

Serum Institute of India to use Genticel's Vaxiclase platform to develop pertussis vaccines

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces that it has licensed its Vaxiclase technology to Serum Institute of India Ltd., for use as a component in acellular multivalent combination vaccines including pertussis antigens.

3 Feb 2015

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

Arena Pharmaceuticals, Inc. today announced that Ildong Pharmaceutical Co., Ltd., has informed Arena that the Ministry of Food and Drug Safety has approved BELVIQ (lorcaserin HCl) for marketing for weight management in South Korea. Ildong will market and distribute BELVIQ in South Korea under its marketing and supply agreement with Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, or Arena GmbH.

3 Feb 2015

BioTrackTHC, Adherence Colorado form strategic alliance

BioTrackTHC, the top provider of seed-to-sale software solutions for medical and retail marijuana businesses, today announced a strategic alliance with Adherence Colorado, the leading provider of compliance audits and inventory reconciliation for the cannabis industry.

3 Feb 2015

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Theravance Biopharma, Inc. and Mylan Inc. today announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

2 Feb 2015

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

2 Feb 2015

Concord Medical's shareholders adopt special resolution to create super voting class of shares

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that a special resolution was adopted by the Company's shareholders at its annual general meeting for the fiscal year ended December 31, 2014 held in Beijing on January 27, 2015 to create a super voting class of shares.

2 Feb 2015

Sutter Health reaches fair and reasonable agreement with Blue Shield of California

The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.

31 Jan 2015

eRelevance closes seed funding of more than $1.4 million

eRelevance Corporation, announced today that it has closed a round of seed funding of more than $1.4 million.

31 Jan 2015

GNC Holdings declares quarterly cash dividend for first quarter 2015

The Board of Directors of GNC Holdings, Inc. authorized and declared the quarterly cash dividend for the first quarter of 2015 of $0.18 per share of the Company's common stock, representing a 12.5% increase over its prior quarterly dividend.

31 Jan 2015

JetFuel Technologies, Valtronic team up to reduce brain injuries

Valtronic develops partnerships built on the creation of innovative ideas, technology, and positive outcomes for all.

31 Jan 2015

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014.

30 Jan 2015

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.

30 Jan 2015

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).

30 Jan 2015

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.

29 Jan 2015

Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nanoscale metrology products, proudly introduces Park NX-Bio, a powerful 3-in-1 bio-research tool that uniquely combines scanning ion conductance microscopy (SICM) with AFM and an inverted optical microscope (IOM) on the same platform.

29 Jan 2015

Marie Csete appointed president and chief scientist of HMRI

Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.

29 Jan 2015

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening.

27 Jan 2015

Business / Finance

HealthSouth agrees to acquire Cardinal Hill Rehabilitation Hospital from Kentucky Easter Seal Society

Three CRO Enterprise Partners expand agreements with DATATRAK

Serum Institute of India to use Genticel's Vaxiclase platform to develop pertussis vaccines

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

BioTrackTHC, Adherence Colorado form strategic alliance

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Concord Medical's shareholders adopt special resolution to create super voting class of shares

Sutter Health reaches fair and reasonable agreement with Blue Shield of California

eRelevance closes seed funding of more than $1.4 million

GNC Holdings declares quarterly cash dividend for first quarter 2015

JetFuel Technologies, Valtronic team up to reduce brain injuries

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Marie Csete appointed president and chief scientist of HMRI

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News